The Royal Marsden NHS Foundation Trust has become the first medical centre in the world to clinically use two groundbreaking technologies in robotic-assisted microsurgery, developed by Medical Microinstruments, (MMI).
The case, conducted at the specialist cancer hospital in London, featured the debut of MMI’s NanoWrist dissection instruments and Synaptix Digital Surgery Platform, both designed to enhance precision and efficiency in complex surgical procedures.
READ MORE: Cobionix secures US$3m to advance autonomous medical robots
MMI unveiled the technologies as part of its Symani Surgical System. The technology enables refined tissue dissection and introduces a fully integrated digital workflow into the operating theatre.
The NanoWrist instruments, comprising robotic scissors and forceps, are the first fully-wristed tools engineered specifically for open microsurgery.
They allow surgeons to perform delicate dissection and fine tissue manipulation.
The scissors are designed for precise cutting of soft tissue during procedures such as vessel preparation and tumour resection, while the forceps facilitate gentle handling of blood vessels.
Alongside the instruments, the Synaptix Digital Surgery Platform provides data-driven visual enhancements and workflow tools tailored to microsurgical needs.
Built to integrate with the Symani system, it is the first digital platform of its kind for open microsurgery, offering improved consistency, faster case setup, and enhanced coordination among surgical teams.
Innovative applications of cobots, manufacturing, AI in retail and e-commerce, healthcare and pharmaceuticals, food and beverage, automotive, transport & logistics, and more will be celebrated at the Robotics & Automation Awards on 29 October 2025 at De Vere Grand Connaught Rooms in London. Visit www.roboticsandautomationawards.co.uk to learn more about this unmissable event for the UK’s robotics and automation sectors!
